期刊文献+

乏氧照射双敏感启动子HRE.CArG调控HSVtk基因对肺癌细胞的杀伤效应 被引量:5

Hypoxia/radiation dual-sensitive promoters enhance the toxicity of HSVtk-mediated gene-directed enzyme prodrug therapy in Lung Cancer Cells
下载PDF
导出
摘要 目的观察乏氧照射后HRE.CArG融合性启动子诱导增强的绿色荧光蛋白(EGFP)在SPCA1和A549肺癌细胞株中的表达变化及乏氧照射诱导下该启动子驱动自杀基因HSVtk对肺癌细胞的杀伤作用。方法用聚乙烯亚胺转染法转染SPCA1和A549细胞,乏氧照射后24 h测EGFP表达强度;乏氧照射后24 h加入GCV,48 h后用MTT法测定细胞存活率。结果乏氧照射后转染pDNA.HRE.CArG.EGFP质粒的SPCA1和A549细胞EGFP表达强度分别是对照组的(3.37±0.23)倍和(3.10±0.28)倍(P<0.01);转染pDNA.HRE.CArG.HSVtk质粒的SPCA1和A549细胞存活率较对照组分别降低(63.23±2.31)%和(76.58±2.19)%(P<0.01)。结论质粒载体中包含的HRE.CArG元件对乏氧照射敏感,乏氧照射后通过诱导下游的HSVtk基因大量表达,使转染细胞对GCV的敏感性增高,而大大增加对SPCA1和A549细胞的杀伤效应。 Objective To observe the expression of the enhanced green fluorescent protein (EGFP) induced by chimeric hypoxia/radiation responsive elements (HRE. CArG) in existence of hypoxia and radiation in SKA1 and A549 lung cancer cells; to examine the toxicity of such promoters responsive to hypoxia and radiation to control the expression of HSVtk - mediated gene - directed enzyme predrug therapy (GDEPT) to kill lung cancer cells.Methods Transient transfectants with the EGFP- constructs were obtained by exposing the SKA1 and A549 cells to complexes of DNA, polyethylenimine (PEI) for efficient transfection. The cells were exposed to hypoxia and radiation 24 h after transfection. Relative EGFP fluorescence was measured by flow cytometery; HSVtk - constructs were transfected into the hypoxic and irradiated SKA1 and A549 cells,then the cells were exposed to media containing ganciclovir (GCV) for 24 h.Two days later,the cell growth rate was detected by MTT assay. Results The EGFP expression was increased in the transfected cells with plasmids of pDNA. HRE. CArG. EGFP. Compared with the corresponding aerobic/sham - irradiated sample transfected with the same plasmid, survival of SKA1 and A549 cells transiently transfected with the pDNA. HRE. CArG. HSVtk plasmid in hypoxia and radiation and GCV exposure group reduced (63.23 ± 2.31 )% and (76.58± 2.19)%( P 〈0.01) ,respectively. Conclusions The promoters we constructed respond to hypoxia and radiation.The addition of GCV to hypoxia and irradiation significantly reduces plasmid - transfected cells' survival.
出处 《武警医学》 CAS 2007年第12期907-911,共5页 Medical Journal of the Chinese People's Armed Police Force
基金 山东省重大攻关项目(NO.031050102)
关键词 乏氧 放射治疗 基因治疗 肺癌 Hypoxia Radiation therapy Gene therapy Lung cancer
  • 相关文献

参考文献10

  • 1Weichselbaum RR, Kufe DW, Advani SJ et al. Molecular targeting of gene therapy and radiotherapy. Acta Oncol, 2001,40(6) : 735
  • 2Scott SD, Joiner MC, Marples B. Optimizing radiation - responsive gene promoters for radiogenetic cancer therapy. Gene Ther,2002,9(20) : 1396.
  • 3郑爱青,宋现让,于金明,王兴武,魏玲.嵌合性启动子HRE.CArG的构建及对肝癌细胞乏氧和射线应答的调控[J].中国肿瘤生物治疗杂志,2005,12(1):69-71. 被引量:2
  • 4郑爱青,王兴武,韩晨光,魏玲,宋现让.低氧诱导下HRE调控HSVtk基因对肺癌细胞的杀伤效应[J].中华肿瘤防治杂志,2007,14(5):335-338. 被引量:5
  • 5郑爱青,韩晨光,宋现让,于金明,魏玲,王兴武.辐照后辐射敏感启动子CArG调控HSVtk基因对肺癌细胞的杀伤效应[J].中国肿瘤生物治疗杂志,2006,13(2):123-123. 被引量:3
  • 6Marples B, Greco O, Joiner MC et al . Molecular approaches to chemo- radiotherapy.Eur J Cancer,2002,38(2) : 231.
  • 7Takahashi T, Namikiy, Ohno T. Induction of the suicide HSV TK gene by activation of the Egr 1 promoter with radioisotopes. Human Gene Ther, 1997,8(7) : 827.
  • 8Marples B, Scott SD, Hendry JH et al . Development of synthetic promoters for radiation-mediated gene therapy. Gene Ther.2000,7:511.
  • 9Greco O, Marples B, Dachs GU et al . Novel chimeric gene promoters responsive to hypoxia and ionizing radiation. Gene Ther.2002,9(20) : 1403.
  • 10Greco O, Folkes LK, Wardman P et al . Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid. Cancer Gene Ther,2000,7(11) : 1414.

二级参考文献13

  • 1郑爱青,宋现让,于金明,王兴武,魏玲.嵌合性启动子HRE.CArG的构建及对肝癌细胞乏氧和射线应答的调控[J].中国肿瘤生物治疗杂志,2005,12(1):69-71. 被引量:2
  • 2Greco O, Marples B, Joiner MC, et al. How to overcome (and exploit) tumor hypoxia for targeted gene therapy[J]. J Cell Physiol, 2003, 197(3): 312-325.
  • 3Ahmed MM. Regulation of radiation-induced apoptosis by early growth response-1 gene in solid tumors[J]. Curr Cancer Drug Targets, 2004: 43-52.
  • 4Scott SD, Joiner MC, Marples B. Optimizing radiation-responsive gene promoters for radiogenetic cancer therapy[J]. Gene Ther, 2002,9(20): 1396-1402.
  • 5Greco O, Marples B, Dachs GU, et al. Novel chimeric gene promoters responsive to hypoxia and ionizing radiation[J]. Gene Ther, 2002, 9: 1403-1411.
  • 6Harrison L,Blackwell K.Hypoxia and anemia:factors in decreased sensitivity to radiation therapy and chemotherapy?[J].Oncologist,2004,9(Suppl 5):31-40.
  • 7Zhu H,Jackson T,Bunn H F.Detecting and responding to hypoxia[J].Nephrol Dial Transplant,2002,17(Suppl 1):3-7.
  • 8Yeo E J,Chun Y S,Park J W.New anticancer strategies targeting HIF-1[J].Biochem Pharmacol,2004,68(6):1061-1069.
  • 9Semenza G L.Targeting HIF-1 for cancer therapy[J].Nat Rev Cancer,2003,3(10):721-732.
  • 10Ido A,Uto H,Moriuchi A,et al.Gene therapy targeting for hepatocellular cancinoma:selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter[J].Cancer Res,2001,61(7):3016-3021.

共引文献5

同被引文献32

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部